Abstract

Antipsychotics are associated with high rates of obesity and type 2 diabetes. Moreover, these agents can immediately and independently of weight gain induce insulin resistance via the central nervous system (CNS). We recently demonstrated that olanzapine abolishes the ability of a CNS insulin infusion to restrain hepatic glucose production and to suppress feeding in rodents. Across rodents and humans, the ATP-sensitive potassium (KATP) channel is a critical metabolic sensor downstream of hypothalamic insulin signaling in maintenance of energy and glucose homeostasis. Here, we examined whether olanzapine inhibits central KATP channels to disrupt glucose metabolism.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call